The Portland Pickles—a collegiate summer baseball wooden bat team based in Portland, Oregon—will become the first sports team in the U.S. to legally sell THC products at live sports events.

The baseball team announced Tuesday an exclusive partnership with Cycling Frog, makers of hemp-derived THC-based seltzer drinks. The team began selling the infused drinks at Walker Stadium in Portland on June 18. Cycling Frog was founded in 2021 and sells a range of hemp-derived, full-spectrum cannabinoid products including THC seltzers, gummies, softgels, and microdose mints

The Oregonian reports that Cycling Frog’s drinks contain 2 mg of THC and 4 mg of CBG per can and will be available in passionfruit and lemon flavors inside the ballpark.

“The Portland Pickles have a responsibility in the sports industry to take leaps and set a precedent of innovative partnerships,” Ross Campbell, VP of Business Development for the Pickles, said in a statement. “As we saw in 2019, becoming the first team to ever partner with a CBD company, and quickly teams all the way up to the Major League level across sports follow suit.”

Since Cycling Frog’s drinks contain hemp-derived THC, people who purchase them must be 21 years of age or older to purchase. How is this legal? According to a statement, the Pickles have consulted on regulations with the Oregon Liquor and Cannabis Commission (OLCC) and Portland Parks and Recreation, which owns the stadium.

The Portland Pickles play at Walker Stadium when they play home games.

KGW reports that the seltzers will be sold at three different locations throughout the stadium: The Jack Daniels Party Deck Bar, Dillon’s Hideaway Bar and a third standalone pop-up inside the gates. People must be 21 years old or older to purchase. 

Stephen Colbert Name-Drops Portland Pickles and THC Drinks

Stephen Colbert even got in on the action, following the news about the Portland Pickles. During the Thursday episode of The Late Show With Stephen Colbert. Toward the end of his opening monologue, Colbert joked about it being the first day of summer, which means baseball.

Colbert joked about the New York Mets, the McDonald’s mascot Grimace throwing out a first pitch at one of their games, and this not being the first time a McDonald’s mascot helped out the New York team.

“Back in 1986, the Hamburglar was their coke dealer,” Colbert said. Switching to baseball’s minor leagues, “and the minor leagues of drugs,” he went on to note that the Portland Pickles have become the first sports team to legally sell THC products at games..

Colbert then said Portland Pickle fans “won’t be sparking up in the stands, you’ll be sparkling up, because instead of smoke-able products, they’ll be selling THC-based seltzer drinks.”

The Portland Pickles X account posted a clip of the video.

Colbert then went on to say that Coca-Cola used to be infused with cocaine, so a THC drink really isn’t all that far-fetched.

That might sound odd, Colbert said, “but remember, Coca-Cola used to have cocaine in it, and ginger ale originally contained the blood of a redhead.”

Cannabis Sales in Portland

Cannabis sales in the city of Portland fell in 2022. According to an OLCC database, Portland, Oregon area pot sales hit the lowest number of sales in three years. However, some experts blame the drop in sales on the temporary pandemic hump.

In June 2022, retail cannabis shops across Multnomah County, the state’s most populous area, made the lowest monthly profit they have since early 2019—hitting just $27,000 on average.

The price of cannabis flower is the lowest it’s been since April 2019. The county’s average gram sells for just $4.29 a gram—quite a bit lower than you’d find in most other states. Some have blamed the drop in value on Oregon’s oversupply problem, while others say the state’s oversupply problem wasn’t quite so bad as reported.

Portland residents bought $21 million worth of flower in July 2020, in the middle of the pandemic—and it was the most cannabis ever purchased in the state in a single month.

In general, cannabis sales increased at a steady pace since they began in 2016, but they skyrocketed in 2020, partly due to working from home and stimulus checks. In the span of only five months, cannabis sales in the county  increased by 79%. On average, cannabis shops raked in $48,000 per month in Multnomah County during the month of July 2020. But sales plunged shortly after, marking the lowest number recorded since June 2019.

Now that cannabis will be available at Portland Pickles games, local residents in the area can now have another way to get THC-infused products.

The post Portland Pickles First Sports Team To Sell THC Products at Games first appeared on High Times.

The post Portland Pickles First Sports Team To Sell THC Products at Games appeared first on Paradise Found.

Looking for a cannabis product to quickly relieve muscle or joint pain? The experts at Rare Cannabinoid Company have created a dispensary-strength THC lotion that can be ordered online and delivered to your doorstep, anywhere in the United States. This powerful CBD cream is the revolutionary brand’s CBG + CBD + THC Rapid Relief Gel. If you click on the product name, you can request a free sample, with free shipping, no credit card necessary.

Rare Cannabinoid Company is best-known for their Mood Gummies (tasty, mood boosting edibles with THC, CBC, and CBD oils) and for creating the world’s first THCV products (for energy and appetite suppression) and pure CBDV oil (for sociability, memory, and reduced irritability). They also offer a vast selection of customized rare cannabinoid gummies, tinctures, topicals, and Pet CBD. 

The premium Hawaiian brand’s new, weightless cooling gel contains a very large amount of three active cannabis / hemp compounds: 1000mg CBG oil, 1000mg CBD oil, and 400mg Delta-9-THC. This trio was specifically chosen for its unique effect in combating soreness and swelling. 

In addition, the powerful pain cream includes arnica for inflammation as well as MSM, menthol, gotu kola, dandelion root extract, aloe vera and more natural, vegan ingredients.

“Our Rapid Relief Gel should be applied directly to the skin in areas experiencing discomfort and soreness for cooling relief,” said a company spokesperson. 

“The special, weightless formula is neither sticky nor oily and it has a mild, refreshing scent. This makes it ideal for use anytime – pre or post workout, before going out or going to bed,” they said.

For added cooling, they recommend storing the bottle in the refrigerator. The gel also absorbs best when massaged into damp skin after a warm shower or bath.

It’s important to note that the high level of Delta-9-THC in this CBD cream is excellent for pain relief, but, since it is applied to the skin, it does not have any psychoactive effects. It can be used by everyone from elite athletes to grandparents, without worrying they’ll get high.

What makes this THC, CBD cream unique?
When looking at cannabis / hemp lotions, there are generally only two types available. Online and in regular stores, CBD creams mostly contain a CBD isolate in a base lotion. Meanwhile, in dispensaries, they contain a mix of CBD and THC oils. However, many products found in dispensaries still only have around 100mg THC and / or CBD. 

Instead, Rare Cannabinoid Company has created a very specialized formula with 2400mg total cannabinoids – one of the most unique and interesting being the inclusion of CBG oil. Despite its high potency and inclusion of THC, this product is legal to sell outside a cannabis dispensary. This is because the CBG + CBD + THC Rapid Relief Gel is Farm Bill compliant. It contains less than 0.3% THC and the only THC in it is naturally derived Delta-9-THC from U.S. hemp plants. 

The Magic Trio – Studies on CBD, THC & CBG
There are more than 100 cannabinoids found in cannabis and hemp and Rare Cannabinoid Company is the pioneer of creating special formulas that go beyond just CBD and THC. 

Here, we’ll take a look at scientific studies on CBD, THC, and CBG for pain and inflammation.

CBD oil (cannabidiol) is well studied for both joint relief and muscle recovery. For example, this animal study found topical CBD effective for arthritis pain and inflammation. Meanwhile, this human trial measured the effects of topical CBD treatment on former professional athletes now living with chronic pain. After six weeks of CBD treatment, the elite athletes reported significant decreases in pain and improvements in function.

Delta-9-THC (delta-9-tetrahydrocannabinol) is also one of the most researched cannabinoids for pain. For example, this medical review  looked at many experiments and concluded that “THC has twenty times the anti-inflammatory potency of aspirin and twice that of hydrocortisone” without the bleeding risks associated with all nonsteroidal anti-inflammatory drugs (NSAIDS).

Although CBG oil (cannabigerol) is less well known than CBD and THC, CBG may have even more pain-relieving properties than THC. This scientific study found “CBG has more potent analgesic (pain-relieving), anti-erythema (anti-inflammatory rash) and lipoxygenase (inflammation) blocking activity than THC. Meanwhile, this scientific study found that CBG may work by blocking the transmission of pain signals.

While each cannabinoid – THC, CBG and CBD – offers relief on its own, this chronic pain study found that “THC + CBD + CBG combined was more effective than these compounds applied alone.” The researchers said results highlighted the potential of using these three specific cannabinoids, particularly in combination.

Cannabinoid Combinations For Every Need
It’s no surprise that this unique Rapid Relief Gel is the brainchild of Rare Cannabinoid Company. The Hawaiian brand offers the largest selection of naturally occurring cannabinoids and specializes in creating blends for specific wellness needs.

Well-known for their apothecary of cannabis / hemp compounds, their new THC + CBG + CBD cream can be used alongside their famous all-natural, vegan gummies for even more relief. 

For added joint and muscle recovery they offer:

CBG Gummies: Each green-apple flavored gummy contains 30mg CBG oil and 10mg CBD oil. These gummies can be taken any time of day as they are non-psychoactive.

THC + CBG Gummies: Each gummy contains 2.5mg Delta-9-THC in addition to 30mg CBG oil and 10mg CBD oil.

Other popular gummies include:

THCV Gummies: For energy, appetite suppression, focus and concentration. Each lemon-flavored gummy contains 12.5mg THCV and 10mg CBD.

THC + THCV Gummies: All the enjoyment of THC minus the munchies and couch-lock. These gummies contain 2.5mg Delta-9-THC and 12.5mg THCV and 10mg CBD.

Mood Gummies (jars): These unique edibles combine the most antidepressant-like cannabinoids to improve one’s mood. Each gummy contains 5mg Delta-9-THC, 5mg CBC oil (cannabichromene), and 10mg CBD oil. 

Mood Gummies (packets): For an on-the-go mood boost of blissfulness, these packets contain 10 Mood Gummies instead of the 30 gummies found in jars. They are the same edibles and each one contains 5mg Delta-9-THC, 5mg CBC oil, and 10mg CBD oil.

CBN Gummies: Sleep gummies each contain 30mg CBN oil and 10mg CBD for a restful night’s sleep without next-day grogginess.

THC + CBN Gummies: 5mg Delta-9-THC intensifies the relaxation and sleep properties of the CBN and CBD in these huckleberry-flavored gummies.

CBD Gummies: For calm, balance, stress and discomfort relief, these strawberry-flavored hemp edibles each contain 30mg CBD oil.

Rare Cannabinoid Company’s full apothecary line also includes pure rare cannabinoid tinctures (CBC, CBDV, CBG, CBN, THCV etc.), full spectrum premium Hawaiian CBD, and their luxury line of Hawaiian Choice broad spectrum Maui CBD products.

All products are manufactured in a cGMP-certified facility and each bath undergoes multiple third-party lab tests to assure its purity and potency. 

See our related High Times article: CBD, Rare Cannabinoid CBDV, Cannabidivarin, Show Great Promise for Autism Spectrum Disorder

Enjoy Free Samples!
Not sure if Rare Cannabinoid Company’s Rapid Relief Gel can help you? You can try a totally free sample packet of the CBD Cream here. Each 3ml packet contains 12mg CBD, 5mg THC, and 12mg CBD. Packets come with free shipping, so no credit card is necessary.

For those who would like to try a CBD pain cream without any THC, Rare Cannabinoid Company also offers Hawaiian Choice CBD Topical Gel. It contains 2000mg premium Hawaiian CBD oil and 400mg CBG oil extracted from hemp plants grown on the slopes of Haleakala Volcano on Maui. Like the CBG + CBD + THC lotion, this Hawaiian CBD cream also contains arnica and other botanicals for added relief. In addition, it is gently scented with eucalyptus and lemongrass essential oils.

Not sure which cannabinoids or products suit your specific needs? Take Rare Cannabinoid Company’s Cannabinoid Finder Quiz to find out. Upon completion, you’ll receive a coupon code for up to 10 gummies ($25 value) free. For the gummies, you will need to pay for shipping or receive free shipping with a qualifying purchase amount. 

Visit Rare Cannabinoid Company to learn more about all the fascinating cannabinoids, their uses, and the products you can find them in. 

The post Pain? Inflammation? Try Rare Cannabinoid Company’s New THC Rapid Relief Gel first appeared on High Times.

The post Pain? Inflammation? Try Rare Cannabinoid Company’s New THC Rapid Relief Gel appeared first on Paradise Found.

Rapid Relief Cooling Gel from Rare Cannabinoid Company combines CBG, CBD & THC in a new formula to tackle muscle & joint discomfort.

The post How Rapid Relief Cooling Gel with CBG, CBD & THC nails the recipe for relief appeared first on Leafly.

The post How Rapid Relief Cooling Gel with CBG, CBD & THC nails the recipe for relief appeared first on Paradise Found.

Looking for recommendations on the hottest 1:1 THC to CBD ratio seeds, autoflowers, mixed ratios and beyond? We’ve got you covered.

The post The best balanced CBD:THC weed seeds in 2024 appeared first on Leafly.

The post The best balanced CBD:THC weed seeds in 2024 appeared first on Paradise Found.

Over one-fifth of adults in America reported using hemp-derived cannabinoids such as cannabidiol (CBD) and delta-8 tetrahydrocannabinol (THC) in a survey of responses collected last summer. 

Researchers not only identified the extent of how popular hemp-derived products are, but emphasized that states that prohibit cannabis lead to a higher rate of delta-8 THC use—probably because that’s all people can get legally in those states.

The study, “Past-Year Use Prevalence of Cannabidiol, Cannabigerol, Cannabinol, and Δ8-Tetrahydrocannabinol Among US Adults,” was published Dec. 13 in the Journal of the American Medical Association (JAMA) and referenced data gathered in a 2019 Gallup poll.

According to the new findings, 25.2% of adults reported past-year use of any emerging hemp-derived cannabinoid, including delta-8 THC, CBD, cannabigerol (CBG), cannabinol (CBN), etc. Of those, 21% of adults said they had used CBD specifically. Other products derived from hemp had lower rates of use: 11.9% of the survey respondents reported using delta-8 THC, 5.2% reported using CBG, and 4.4% reported using CBN—one of the least significant cannabinoids. 

The study was written by doctors Adrianne R. Wilson-Poe, Tristin Smith, Michael R. Elliott, Daniel J. Kruger, and Kevin F. Boehnke. “We provide the first estimates, to our knowledge, of past-year use prevalence of CBN, Δ8-THC, and CBG in the US. A Gallup poll reported that 14% of US adults personally used CBD in 2019; our reported 21% use prevalence of CBD represents a 50% increase over the past 4 years,” researchers wrote. 

“Prevalence of past-year cannabis use was somewhat higher than in other studies but was similarly associated with younger age, and past-year cannabis use was also associated with using emerging cannabinoid products,” the report continues. “Higher Δ8-THC use in states without medical or adult-use cannabis laws suggests that cannabis prohibition may unintentionally promote Δ8-THC use. There are few controlled human studies with emerging cannabinoids, but surveys suggest these products are used for treating sleep or pain¹ and in place of other drugs, including pain medications.”

The researchers noted that hemp products are frequently psychoactive, and these are the main compounds they’re concerned with.

“Based on these results, we support ongoing public health surveillance efforts targeting emerging cannabinoids because of lack of industry standards to protect consumers and similar pharmacology or effects of Δ9-THC and its hemp-derived impairing analogues (eg, Δ8-THC), which may be of particular concern for adolescents and young adults,” the study reports. “Study limitations included not assessing emerging cannabinoid use patterns (eg, dose and use frequency) and possible sampling biases, although NORC implements probability-based recruitment best practices for their AmeriSpeak panel. Our results highlight the importance of future research to better understand perceptions of safety, motivations for use, and outcomes of use of these products.”

Researchers cautioned that the products are not regulated and could put patients at the risk of adverse effects from unknown contaminants. 

The 2018 Farm Bill legalized the cultivation and sale of hemp, and it created a legal loophole, allowing hemp-derived products that are now sold online and at smoke shops, gas stations, and other retailers. 

Medscape reports that the U.S. Food & Drug Administration (FDA) does not regulate hemp-derived products; therefore, no federal standards exist for testing ingredients for safety or verification of ingredients as listed on labels. 

“If someone is picking up one of these products to use medically, and it ends up having heavy metals and pesticides and it doesn’t even have the active ingredient in it, that is not good,” said Kevin F. Boehnke, PhD, a research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center at the University of Michigan in Ann Arbor. 

Prohibition Leads to Delta-8 Use

In states where medical cannabis is legal, residents had 56% lower odds of using delta-8 THC, whereas those in states where adult-use cannabis is legal had 55% lower odds of using delta-8 THC than those surveyed in states without legalization. 

The findings suggest “cannabis prohibition may unintentionally promote delta-8-THC use,” Boehnke and his colleagues wrote. 

Alice Kuo, MD, PhD, a pediatrician and professor of internal medicine and pediatrics at the David Geffen School of Medicine at the University of California in Los Angeles, told Medscape that she has seen a large increase in patients who say they use cannabinoid products, and believe them to be “natural.”

“My official response to patients who ask me for my opinion is that I don’t have enough scientific background to give an opinion: If you think it helps you and you have no side effects, then I’m not going to tell you to stop,” Kuo said. 

The FDA warns about delta-8 THC and similar products, which it says are products that have not been proven to be safe.

The post One Out of Five American Adults Say They’ve Tried Hemp-Derived Products, Study Indicates appeared first on High Times.

The post One Out of Five American Adults Say They’ve Tried Hemp-Derived Products, Study Indicates appeared first on Paradise Found.

Rare cannabinoid gummies from Rare Cannabinoid Company now include options both with and without delta-9 THC.

The post Rare cannabinoid gummies get a buzzy upgrade, featuring new options with and without delta-9 THC appeared first on Leafly.

The post Rare cannabinoid gummies get a buzzy upgrade, featuring new options with and without delta-9 THC appeared first on Paradise Found.

Helichrysum umbraculigerum, or the woolly umbrella plant, is a velvety yellow perennial herb native to South Africa, and Israeli researchers recently discovered that the plant, which is definitively not a part of the cannabis family, happens to produce a number of cannabinoids that, until now, were believed to belong exclusively to the cannabis and hemp plants. 

The recent discovery could open new avenues for cannabinoid medicines and treatments. The study, titled “Turning a new leaf on cannabinoids,” was conducted by researchers from the Weizmann Institute of Science and published in the journal Nature Plants earlier this month.

Cannabis and the Woolly Umbrella Plant

Researchers have studied cannabinoids and their potential uses for decades. The most well-known cannabinoid tends to be THC, though there are plenty of others that have gained prominence over the years, have little-to-no psychoactive effects and could assist in treating a variety of symptoms and conditions.

While cannabis is known to produce more than 100 different cannabinoids, the research team identified more than 40 cannabinoids found in the woolly umbrella. They also shared the biochemical steps the plant takes as it produces these compounds and how these steps can be reproduced in a laboratory, to synthesize existing cannabinoids or potentially engineer new ones that don’t exist in nature.

“We have found a major new source of cannabinoids and developed tools for their sustained production, which can help explore their enormous therapeutic potential,” said study leader Dr. Shirley Berman of the Weizmann Institute of Science.

The woolly umbrella plant is a relative of daisies, lettuce and sunflowers. It can reach up to one meter in height and is often used to make garden borders. It’s also been known to be burned in folk rituals to release intoxicating fumes, which hints that there might be more under the surface. 

More than four decades ago, German scientists also found evidence that the woolly umbrella contains cannabinoids, though modern studies have failed to reproduce those findings until now. In fact, the research team launched the study of the woolly umbrella specifically to revisit its relationship to cannabinoids and larger potential as a medical aid.

A New Frontier for Cannabinoids?

The research team used state-of-the-art technology to confirm those early reports. Specifically, they sequenced the entire woolly umbrella genome and used advanced analytical chemistry to identify the cannabinoids it contains. Researchers were also able to reveal the precise structure of more than a dozen of the observed cannabinoids, along with other related metabolites. 

They found that the woolly umbrella primarily manufactures cannabis in its leaves, which could be a benefit compared to cannabis, which makes cannabinoids in the shorter-lived, sometimes challenging-to-harvest flower clusters. Regardless, researchers found many commonalities between the two plants; particularly, the enzymes used in each step of cannabinoid production belong to the same families.

Researchers found that six cannabinoids found in the woolly umbrella are identical to those in cannabis. THC and CBD were not among them, though CBG, or cannabigerol, was. CBG has increasingly grown in popularity, as research has continued to reveal its potential therapeutic benefits. Similar to CBD, the cannabinoid also lacks the mood-altering effects that create a “high.”

With cannabis plants specifically, CBG is considered the main precursor to many popular cannabinoids. Namely, THCA, CBDA and CBCA all start as CBG’s acidic form, CBGA, which often leaves little CBG for harvest among mature plants. Growers have explored workarounds to maximize CBG production, but the woolly umbrella could pave the way to another solution.

A Promising Finding for Future Exploration

Additionally, researchers noted that there is an ecological point of view to further examine. Scientists still don’t fully understand why plants produce cannabinoids, though some evidence suggests it may help to deter predators or offer protection from ultraviolet rays.

“The fact that in the course of evolution two genetically unrelated plants independently developed the ability to make cannabinoids suggests that these compounds perform important ecological functions,” said Professor Asaph Aharoni, whose lab was used for the study. “More research is needed to determine what these functions are.”

Moving forward, the study findings may allow scientists to engineer cannabinoids that don’t exist in nature, allowing for better binding to human cannabinoid receptors or even specific therapeutic effects. The cannabinoids specific to the woolly umbrella plant could also hold untapped potential.

“The next exciting step would be to determine the properties of the more than 30 new cannabinoids we’ve discovered, and then to see what therapeutic uses they might have,” Berman said.

The post Cannabinoids Found in Non-Cannabis Plant Woolly Umbrella appeared first on High Times.

The post Cannabinoids Found in Non-Cannabis Plant Woolly Umbrella appeared first on Paradise Found.

Raphael Mechoulam, the first person to synthesize THC, earning him the moniker the “Father of Cannabis Science,” has died, Analytical Cannabis reports. He was 92 years old, and his legacy will most certainly live on for centuries to come. The esteemed chemist is also called the father of cannabis research. Some of his additional game-changing contributions to drug science include isolating and synthesizing other cannabinoids, such as cannabidiol (CBD), cannabigerol (CBG), and cannabichromene (CBC). 

While THC, CBD, and CBG are basically household names today, that would not be the case if it weren’t for Dr. Mechoulam, so smoke one out for him in remembrance. A medicinal chemistry professor at the Hebrew University of Jerusalem in Israel, his work laid the groundwork and got the ball (or blunt) rolling to prompt future breakthroughs, such as illumination into the human body’s internal cannabinoid receptors in the 1980s and ’90s, as detailed in the 1993 academic paper titled Molecular characterization of a peripheral receptor for cannabinoids. 

Make sure to pay your respects today, as Dr. Mechoulam’s friends and fellow scientists are, as you pass the peace pipe around with your buddies. “This is a very sad day for me, for the science community and for the cannabis community. Professor Raphael Mechoulam or as we called him Raphi, was one of the greatest scientist[s] I ever met and was my teacher and mentor in many aspects. I truly believe he [deserved] a Nobel prize!” wrote David “Dedi” Meiri, an associate professor at Technion, the Israel Institute of Technology, and one Mechoulam’s colleagues, in a touching online statement. “Thank you Raphi for all the great things you did and discover[ed] in your life and thanks for all the help and support you gave me. Rest in peace my dear friend,” he continues. 

Born in Sofia, Bulgaria, in 1930, Mechoulam and his family relocated to Israel, where he began studying chemistry. His inspiration to start his successful hunt for THC began after wise observance of other drugs’ mechanisms. In an interview with CNN in 2014, Mechoulam pointed out that: “Morphine had been isolated from opium in the nineteenth century, early nineteenth century, cocaine had been isolated from coca leaves [in the] mid-nineteenth century. And here we were, mid-twentieth century, and yet the chemistry of cannabis was not known. So it looked like [an] interesting project.” According to the National Library of Medicine, in 1964, he succeeded. And the story behind how Mechoulam obtained the cannabis he studied may surprise you. 

While working as a chemist in the early 1960s at the Weizmann Institute, Mechoulam got some weed from the Israeli police with his goal already in place: to discover and isolate what makes pot psychoactive. Once THC and other cannabinoids, such as the aforementioned CBD and CBG, were identified, in 1992, Mechoulam and his team discovered the chemical arachidonoyl ethanolamine, which you know as anandamide (derived from the Sanskrit word ananda, which means bliss). Anandamide is something our body’s endocannabinoid system produces on its own (as if we are built to use cannabis) and activates the CB1 receptor. 

Deeply passionate and hardworking, Mechoulam continued his research right up to his death. At the age of 88, at the cannabis conference CannMed in California in 2019, he announced another breakthrough, synthetically stable cannabidiolic acid (CBDA), the main phytocannabinoid in fiber and seed-oil hemp, which contains anti-inflammatory, anti-convulsant, and anti-cancerogenic properties, and that’s likely just the tip of the iceberg. “We have taken the unstable acid molecules of the cannabis plant and synthesized them to provide a stable, consistent basis for researching new therapies across a wide range of medical needs,” Mechoulam explained at the conference. He also used his stage time to encourage the scientific community to invest more into cannabis research, as enough time has already been lost, citing the many people from the past who would have vastly benefited from medicinal cannabis should it have been available. “Did we have to wait 30 years? No,” he said. “We could have helped thousands of children, and we didn’t.” 

Rest in Power, Dr. Mechoulam, and may everyone lucky enough to have access to the results of his work enjoy the power of plant medicine today. 

The post ‘Father of Cannabis Science’ Raphael Mechoulam Dead at 92 appeared first on High Times.

The post ‘Father of Cannabis Science’ Raphael Mechoulam Dead at 92 appeared first on Paradise Found.

Rosin gummies and chocolate, potent cookies, and gravy. Happy Danksgiving.

The post America’s tastiest holiday edibles ’22 appeared first on Leafly.

The post America’s tastiest holiday edibles ’22 appeared first on Paradise Found.

Rare Cannabinoid Company offers one of the most comprehensive suites of cannabinoid tinctures & gummies available anywhere.

The post The rise of rare cannabinoids: An inside look with Rare Cannabinoid Company appeared first on Leafly.

The post The rise of rare cannabinoids: An inside look with Rare Cannabinoid Company appeared first on Paradise Found.